April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
In Vivo Evaluation Of Retinal Neurodegeneration In Patients With Multiple Sclerosis
Author Affiliations & Notes
  • Gabor M. Somfai
    Department of Ophthalmology,
    Semmelweis University, Budapest, Hungary
  • Erika Tátrai
    Department of Ophthalmology,
    Semmelweis University, Budapest, Hungary
  • Magdolna Simo
    Department of Neurology,
    Semmelweis University, Budapest, Hungary
  • Anna Iljicsov
    Department of Neurology,
    Semmelweis University, Budapest, Hungary
  • János Németh
    Department of Ophthalmology,
    Semmelweis University, Budapest, Hungary
  • Delia DeBuc
    Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
  • Footnotes
    Commercial Relationships  Gabor M. Somfai, Carl Zeiss AG (C); Erika Tátrai, None; Magdolna Simo, None; Anna Iljicsov, None; János Németh, None; Delia DeBuc, PCT/US2009/068653 (P)
  • Footnotes
    Support  JDRF grant 2007-727, NIH grant P30-EY014801, unrestricted grant to the University of Miami from Research to Prevent Blindness, Inc. and the Zsigmond Diabetes Fund of the Hungarian Academy of Sciences
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2999. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gabor M. Somfai, Erika Tátrai, Magdolna Simo, Anna Iljicsov, János Németh, Delia DeBuc; In Vivo Evaluation Of Retinal Neurodegeneration In Patients With Multiple Sclerosis. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2999.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate macular morphology in patients with multiple sclerosis (MS).

Methods: : Optical coherence tomography (OCT) examination was performed in twenty-three patients with MS and three patients with previous unilateral ON as a clinically isolated syndrome. The raw macular OCT data were processed using OCTRIMA software. Weighted mean thickness (WMT) of the total retina and 5 intraretinal layers were obtained. The eyes of MS patients were divided into 2 groups; the first group was composed of 26 ON-affected eyes (AE group), while the remaining 23 eyes had no history of ON (non-affected eyes - NE group). Thickness values were compared using ANOVA with Newman-Keuls post-hoc analysis. ROC curves were constructed to determine which parameter can discriminate best between ON-affected and healthy eyes.

Results: : The WMT of the macula, RNFL and ganglion cell layer and inner plexiform layer complex (GCL+IPL) was significantly decreased in the NE group compared to controls (p=0.002, 0.001 and <0.001, respectively) and in the AE group compared to NE group (p<0.001 for each comparison). The largest AUC (1.0) was obtained for the WMT of the ganglion cell complex (comprising the RNFL and GCL+IPL).

Conclusions: : Thinning of the ganglion cell complex in the inner retina is present in both the ON-affected and non-affected eyes of MS patients. Macular OCT image segmentation might provide a better insight into macular and general pathology of neurodegeneration and could therefore play an important role in the diagnosis and follow-up of patients with MS.

Keywords: ganglion cells • neuro-ophthalmology: diagnosis • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×